BIT's 8th World Congress of Industrial Biotechnology
Conference Report

On April 25-28, 2015, BIT's 8th Annual World Congress of Industrial Biotechnology-2015 (ibio-2015) was successfully held in Nanjing International Youth Conference Hotel. Almost 300 participants from over 29 countries and regions shared their research in the conference ibio-2015.

Among them the plenary keynote speakers are Dr. Xiucai Liu, Founder, Chairman & CEO, Cathay Industrial Biotech Ltd., China; Dr. Claus Crone Fuglsang, Vice President of BioEnergy Research and Development, Novozymes, Inc, Denmark; Dr. Jei-Fu Shaw, President &Chair Professor, I-Shou University, Taiwan; Prof. German Spangenberg,Executive Director, Department of Economic Development, Jobs, Transport and Resources, La Trobe University, Australia; Dr. Baoguo Sun, Head of Central Service R&D, Codexis Laboratories Singapore, Singapore.

Throughout the conference, the total 9 sessions covered the topics: The Future of Bio-energy: Advanced Technology, Challenges, Trend and Opportunities; Biomass Feedstock and Advanced Biomass Conversion Technologies; Breakthrough in Ligno-Cellulose Bioethanol and Other Biofuels; Biologic Pharmaceutical Development; Biomarkers, Molecular Diagnostics/Prognostics, and Biomedical Devices;Environmental Biotechnology; Agriculture and Plant Biotechnology; Innovative Biomaterials; 2nd Annual International Symposium of Industrial Microbiology (ISIM-2015).

After the conference, many participants expressed their satisfaction with the content of the congress. We also appreciate your precious opinion and suggestions to us. With the great support and suggestions from all of the participants, we are quite confident in organizing ibio-2016 in Korea. We are looking forward to meeting you again. If you are interested in ibio-2016, please contact Amy at

Nobel Laureate Forum of DNA and Genome Day-2015

Dr. Bruce A. Beutler,
Professor, UT Southwestern,

Nobel Prize laureate in Physiology or Medicine, 2011

Dr. Tim Hunt,
Emeritus Group Leader, Clare Hall Laboratories, UK

Nobel Prize laureate in Physiology or Medicine, 2001

Keynote Speakers

Dr. Claus Crone Fuglsang,
Vice President of BioEnergy Research
and Development, Novozymes, Inc, Denmark

Dr. Jei-Fu Shaw,

President &Chair Professor, I-Shou University, Taiwan

Dr. German Spangenberg, 
Executive Director, Department of Environment 
and Primary Industries; President, International
Association for Plant Biotechnology , Australia

Dr. Xiucai Liu, Founder,

Chairman & CEO, Cathay Industrial Biotech Ltd., China

Dr. Claus Crone Fuglsang
As the Vice President for BioEnergy, Claus Fuglsang is leading Novozymes research in these areas and he oversees a portfolio of projects with more than 150 employees. As such, Claus has played a big part in the development of the first commercial cellulosic ethanol enzymes, Novozymes’ Cellic® CTec range as well as novel products in the existing grain based ethanol industry.
Dr. Mark A. Emalfarb
Mark A. Emalfarb is the founder of Dyadic. He has been a member of Dyadic’s board of directors since October 2004 and has served as its Chairman as well as President and Chief Executive Officer of Dyadic from October 2004 until April 2007 and from June 2008 until the present. Since founding the predecessor to Dyadic in 1979, Mr. Emalfarb has successfully led and managed the evolution of Dyadic from its origins as a pioneer and leader in providing ingredients used in the stone-washing of blue jeans to the discovery, development, manufacturing and commercialization of specialty enzymes used in various industrial applications and the development of an integrated technology platform based on Dyadic’s patented and proprietary C1 fungal microorganism. Mr. Emalfarb is an inventor of over 25 U.S. and foreign biotechnology patents and patent applications resulting from discoveries related to the Company’s patented and proprietary C1 fungus, and has been the architect behind its formation of several strategic research and development, manufacturing and marketing relationships with U.S. and international partners. Mr. Emalfarb earned his B.A. degree from the University of Iowa in 1977.
Dr. Xiucai Liu
Dr. Xiucai Liu is the chairman of Cathay Industrial Biotech, Ltd. He graduated with a Bachelor’s degree from the University of Science and Technology of China and went abroad in the 1980s to obtain his Ph.D. in Biochemistry from the University of Wisconsin in the United States, followed by postdoctoral research at Yale and Columbia and then a position as a senior scientist at the Sandoz Research Institute. In 1997 he founded Cathay Industrial Biotech, which developed bioprocess long chain diacids to take over half the world chemical market for that product and achieved large scale commercialization of second generation biobutanol technology. Recently he has led the development of commercial scale technology to produce biobased diamine, launching the world’s first comprehensive biobased polyamide series. Dr. Liu served as the first chairman of the Sino American Pharmaceutical Association, the largest professional organization for overseas Chinese; won the 10 Cutting Edge “Sea Turtle” Returnee Entrepreneurs Award and the Elite Returnee Entrepreneur Award; he was also selected by Biofuels Digest as one of “The Top 100 People in Bioenergy, 2011-2012.”
Program Layout
Cluster 1 Main Conference
Part One: Part Two:
Opening Ceremony and Nobel Laureate Forum Keynote Forum
Cluster 2 Scientific Program
Stream 1: Bioenergy Development Stream 2: Pharmaceutical and Medical Biotech
Stream 3: Environmental Biotechnology Stream 4: Agriculture and Plant Biotechnology
Stream 5: Innovative Biomaterials 2nd Annual International Symposium of Industrial Microbiology (ISIM-2015)
Cluster 3 Business Development

• Industrial Sponsored Symposia  
• SME’s CEO Forum on Entrepreneurship
• Investor’s Forum
• Project Road Show
• Matchmaking and Biopartnering
• Round Table Discussion
• 1-to-1 Networking
• Lunch Showcase

Cluster 4 Posters and EXPO
• Posters Sessions

• Product and Technology Exhibition
Why Reserve a Booth at ibio-2015
• Meet face to face with key leaders in the field of protein and peptide Science and technology
• Explore new business opportunities both at home and abroad
• Spotlight your advanced technologies and their scientific and commercial applications
• Have the opportunity to network with those attending the conference in the exhibition hall
Cluster 5 Social Events
• Culture Activities-Art Performance and Show
• Cocktail Social Networking
• City Tour As Requested
• Field Trip to Universities/Industries, and Networking Tour
Conference Brochure
News Released

• REGISTER NOW to secure your attendance
• Program released already!
• Speaking proposals are now being accepted, submit the abstract right now

Hosting Organizations

China Council for the Promotion of International Trade

Nanjing Municipal Government
Supporting Organization

Information Research Center of International Talent, SAFEA

Operating Organizations

Economic Information Department, China Council for the Promotion of International Trade

Nanjing Economic and Information Commission

The Bureau of the Nanjing Food and Drug Administration

Nanjing Municipal Investment Promotion Commission

Nanjing Municipal Health Bureau

China Council for the Promotion of International Trade, Nanjing Sub-Council

Zhen-Ao Group

BIT Congress Inc.

Official Travel Agency

BIT World Travel Service, Inc.


Renowned Speakers
Dr. Charlie Xu,
Sr, Director, Clinical Development, BioSciKin Inc, China
Dr. Charles Zhou,
President, Chairman and CEO, Cascade Clean Energy, Inc., USA
Mr. Richard Fish,
President, Alter Nrg Corp., Canada
Dr. Yom-Tov Samia,
President and CEO, IC Green Energy LTD, Israel
Dr. Roland A. Jansen,
CEO, Biomass Partners Ltd.; Director Biomass Investments, Green Investment Solutions Holding PLC, Switzerland
Dr. Paul O'Connor,
Founder, BIOeCON, The Netherlands
Dr. Surajit Khanna,
Chairman and CEO, BARD Holding, Inc, USA
Dr. Jing Liu,
CCo-founder,Owner, CTO, Bioprocess Control AB, Sweden
Dr. Virginia Klausmeier,
CEO and Co-founder, Sylvatex Biofuels, USA
Dr. Salee Amina Mohammed,
Co-owner, Royal Green Bio-Tech; President, Domino Dynamics, USA
Dr. Daniel Siegel,
VP Technology & IP Assessment, FuturaGene, Ltd., Israel
Dr. Xujin Lu,
Senior Principal Scientist, Bristol-Myers Squibb Company, USA
Dr. Silvan de Boer,
Senior Sustainability Officer, Eneco, The Netherlands
Dr. Giulio Tarro,
DPresident, Foundation T. & L. de Beaumont Bonelli for cancer research, Italy
Dr. Ronald Zwart,
Director Biomass Consultancy and Project Development, CKade BV, The Netherlands
Dr. Rajesh C Shrotriya,
Chairman and Chief Executive Officer, Spectrum Pharmaceuticals, Inc., USA
Ms. Vivian Lee,
Managing Director, Aqua Partners LLC, USA
Dr. Ying Ji,
Vice President, Paritic Inc, USA
Dr. Richard Hurding,
CEO, Zelfo Technology GmbH; Owner. Omodo GmbH, Germany
Mr. Rowan Williams,
Regional Market Development Manager - Advocacy, BASF Australia Limited, Australia
Dr. Eyal S Ron,
CTO,Gelesis, USA
Dr. Christophe Reuzeau,
Senior Licensing Manager ASIA Pacific, CropDesign BASF Plant Science, Belgium
Dr. Narender Nehra,
Director, Donald Danforth Plant Science Center, USA
Dr. Dotan Peleg,
CEO, Morflora, Israel
Dr. Henning Trozelli,
Director, Dow AgroSciences LLC, USA
Dr. John Baker,
President, Alan Environmental, LLC, USA
Mr. John Williams,
President & CEO, In-Pipe Technology Company, USA
Dr. Kasiviswanathan Muthukumarappan,
Professor, South Dakota State University, USA
Dr. Donghai Wang,
Professor, Biological and Agricultural Engineering, Kansas State University, USA
Dr. Syed Ubaidullah Hussainy,
Professor, Victoria University, Australia
Dr. Jutta Geldermann,
Professor, Vice-Dean of the Faculty, Georg-August-Universitat Gottingen, Germany
Prof. Dr. Dr. Rolf G. Werner,
Professor Industrial Biotechnology, University of Tuebingen, Germany
Dr. Jamil Baghdachi,
Professor, Eastern Michigan University, USA
Dr. Xiuzhi Susan Sun,
University Distinguished Professor, Kansas State University, USA
Dr. José Kenny,
Professor, University of Perugia, Italy
Dr. Ray T. Chen,
Professor, University of Texas at Austin, USA
Dr. Somenath Mitra,
Professor, New Jersey Institute of Technology, USA
Dr. Pedro Alvarez,
Professor and Chair, Rice University, USA
Dr. Daniel Y.C. Fung,
Professor, Kansas State University, USA
Dr. Dewey D. Y. Ryu,
Professor, University of California, USA
Dr. Xiucai Liu, Founder,
Chairman & CEO, Cathay Industrial Biotech Ltd., China

BIT’s Upcoming Events
Contact Us

Add: East Area, F11, Building 1, Dalian Ascendas IT Park, 1 Hui Xian Yuan, Dalian Hi-tech Industrial Zone, LN 116025, China]
Tel: 0086-411-84799609, Fax: 0086-411-84796897
Copyright © 2014-2015 BIT Congress Inc.